Ilhan, Harun http://orcid.org/0000-0003-0409-1942
Lindner, S.
Todica, A.
Cyran, C. C.
Tiling, R.
Auernhammer, C. J.
Spitzweg, C.
Boeck, S.
Unterrainer, M.
Gildehaus, F. J.
Böning, G.
Jurkschat, K.
Wängler, C.
Wängler, B.
Schirrmacher, R.
Bartenstein, P.
Article History
Received: 6 June 2019
Accepted: 21 August 2019
First Online: 6 September 2019
Compliance with ethical standards
:
: HI is an advisory board member of Bayer, received research funding from Novartis and speaker honoraria from Bayer and Ipsen. CA received research contracts from Ipsen, Novartis, and ITM Solucin; lecture honoraria from Ipsen, Novartis, and Falk Foundation; and advisory board honoraria from Novartis. CS received research grants from Novartis; lecture honoraria from Ipsen and Novartis; and advisory board honoraria from Ipsen, Novartis, and Pfizer. All other authors declare no competing interests.
: All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.